Neuroscience & Biobehavioral Reviews,
Год журнала:
2024,
Номер
165, С. 105867 - 105867
Опубликована: Авг. 28, 2024
Neurodegenerative
diseases
(NDDs)
are
a
series
of
disorders
characterized
by
the
progressive
loss
specific
neurons,
leading
to
cognitive
and
locomotor
impairment.
NDDs
affect
millions
patients
worldwide
but
lack
effective
treatments.
Dysregulation
lipids,
particularly
accumulation
lipid
droplets
(LDs),
is
strongly
implicated
in
pathogenesis
NDDs.
How
LDs
contribute
occurrence
development
NDDs,
their
potential
as
therapeutic
targets
remain
be
addressed.
In
present
review,
we
first
introduce
processes
formation,
transportation
degradation.
We
then
highlight
how
contributes
cell
type-specific
manner.
Moreover,
discuss
currently
available
methods
for
detecting
elaborate
on
LDs-based
strategies
Lastly,
identify
gaps
that
need
filled
better
leverage
LD-based
theranostics
other
diseases.
hope
this
review
could
shed
light
role
facilitate
novel
Nutrients,
Год журнала:
2024,
Номер
16(9), С. 1352 - 1352
Опубликована: Апрель 30, 2024
In
this
study,
a
systematic
review
of
randomized
clinical
trials
conducted
from
January
2000
to
December
2023
was
performed
examine
the
efficacy
psychobiotics—probiotics
beneficial
mental
health
via
gut–brain
axis—in
adults
with
psychiatric
and
cognitive
disorders.
Out
51
studies
involving
3353
patients
where
half
received
psychobiotics,
there
notably
high
measurement
effectiveness
specifically
in
treatment
depression
symptoms.
Most
participants
were
older
female,
treatments
commonly
utilizing
strains
Lactobacillus
Bifidobacteria
over
periods
ranging
4
24
weeks.
Although
general
agreement
on
variability
approaches
presentations
limits
comparability
generalization
findings.
This
underscores
need
for
more
personalized
optimization
deeper
investigation
into
mechanisms
through
which
psychobiotics
act.
The
research
corroborates
therapeutic
potential
represents
progress
management
Experimental Gerontology,
Год журнала:
2024,
Номер
194, С. 112497 - 112497
Опубликована: Июнь 27, 2024
The
gut
microbiome
plays
a
crucial
role
in
host
health
throughout
the
lifespan
by
influencing
brain
function
during
aging.
microbial
diversity
of
human
decreases
aging
process
and,
as
consequence,
several
mechanisms
increase,
such
oxidative
stress,
mitochondrial
dysfunction,
inflammatory
response,
and
dysbiosis.
Moreover,
evidence
indicates
that
neurodegeneration
are
closely
related;
consequently,
may
serve
novel
marker
elderly.
In
this
narrative
study,
we
investigated
how
changes
composition
occur
influence
to
various
neuropathological
disorders,
mild
cognitive
impairment
(MCI),
dementia,
Alzheimer's
disease
(AD),
Parkinson's
(PD);
which
possible
govern
relationship
between
impairment.
addition,
studies
suggest
be
potential
target
improve
hallmarks
promote
healthy
cognition;
therefore,
current
future
therapeutic
interventions
have
been
also
reviewed.
Current Opinion in Neurology,
Год журнала:
2024,
Номер
37(2), С. 166 - 181
Опубликована: Янв. 24, 2024
Purpose
of
review
All
human
beings
undergo
a
lifelong
cumulative
exposure
to
potentially
preventable
adverse
factors
such
as
toxins,
infections,
traumatisms,
and
cardiovascular
risk
factors,
collectively
termed
exposome.
The
interplay
between
the
individual's
genetics
exposome
is
thought
have
large
impact
in
health
outcomes
cancer
disease.
Likewise,
growing
body
evidence
supporting
idea
that
explain
sizable
proportion
Alzheimer's
disease
related
dementia
(ADRD)
cases.
Recent
findings
Here,
we
will
most
recent
epidemiological,
experimental
preclinical,
interventional
clinical
studies
examining
some
these
modifiable
for
ADRD.
We
focus
on
new
regarding
air
pollution,
viral
other
infectious
agents,
traumatic
brain
injury,
hearing
loss.
Summary
While
greater
higher
quality
epidemiological
needed
unequivocally
confirm
their
causal
link
with
ADRD
and/or
unravel
underlying
mechanisms,
may
represent
window
opportunity
reduce
incidence
prevalence
at
population
level
via
screenings,
education
policies.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Фев. 20, 2024
Various
microbial
communities
reside
in
the
gastrointestinal
tract
of
humans
and
play
an
important
role
immunity,
digestion,
drug
metabolism,
intestinal
integrity,
protection
from
pathogens.
Recent
studies
have
revealed
that
gut
microbiota
(GM)
is
involved
communication
with
brain,
through
a
bidirectional
network
known
as
gut-brain
axis.
This
involves
humoral,
immunological,
endocrine,
neural
pathways.
Gut
dysbiosis
negatively
impacts
these
pathways,
leading
to
neurological
complications
cognitive
deficits.
Both
pre-clinical
clinical
demonstrated
probiotics
can
restore
healthy
GM,
reduce
pH,
inflammation
pathogenic
microbes
gut.
Additionally,
improve
cell-to-cell
signaling
increase
blood-brain-derived
neurotrophic
factors.
Probiotics
emerge
potential
approach
for
preventing
managing
Despite
promising
findings,
safety
concerns
possible
risks
probiotic
usage
must
be
closely
monitored
addressed.
review
article
provides
brief
overview
significance
health.
Ageing Research Reviews,
Год журнала:
2024,
Номер
96, С. 102278 - 102278
Опубликована: Март 19, 2024
Vascular
dementia
(VaD)
is
the
second
most
common
type
of
dementia.
VaD
synonymous
with
ageing,
and
its
symptoms
place
a
significant
burden
on
health
wellbeing
older
people.
Despite
identification
substantial
number
risk
factors
for
VaD,
pathological
mechanisms
underpinning
this
disease
remain
to
be
fully
elucidated.
Consequently,
biogerontological
imperative
exists
highlight
modifiable
lifestyle
which
can
mitigate
against
developing
VaD.
This
review
will
critically
examine
some
have
been
revealed
modulate
risk.
The
survey
commences
by
providing
an
overview
putative
are
associated
pathobiology
Next,
influence
examined.
Finally,
emerging
treatment
avenues
including
epigenetics,
gut
microbiome,
pro-longevity
pharmaceuticals
discussed.
By
drawing
key
evidence
together,
it
our
hope
that
used
inform
future
experimental
investigations
in
field.
Alzheimer s & Dementia,
Год журнала:
2024,
Номер
20(8), С. 5771 - 5788
Опубликована: Июнь 28, 2024
Abstract
Over
the
past
decades,
accumulating
evidence
suggests
that
gut
microbiome
exerts
a
key
role
in
Alzheimer's
disease
(AD).
The
Association
Workgroup
is
updating
diagnostic
criteria
for
AD,
which
changed
profiles
and
categorization
of
biomarkers
from
“AT(N)”
to
“ATNIVS.”
Previously,
most
studies
focus
on
correlation
between
amyloid
beta
deposition
(“A”),
initial
AD
pathological
feature
triggering
“downstream”
tauopathy
neurodegeneration.
However,
limited
research
investigated
interactions
other
pathogenesis
(“TNIVS”).
In
this
review,
we
summarize
current
findings
microbial
characteristics
whole
spectrum
AD.
Then,
describe
association
with
updated
biomarker
categories
pathogenesis.
addition,
outline
microbiome‐related
therapeutic
strategies
Finally,
discuss
issues
field
future
directions.
Highlights
new
revised
(AD)
proposed
by
have
associations
are
described.
Current
summarized.
Therapeutic
based
proposed.
Reviews in the Neurosciences,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 20, 2025
Abstract
Recently,
researchers
have
been
interested
in
the
potential
connection
between
gut
microbiota
composition
and
various
neuropsychological
disorders.
Dementia
significantly
affects
socioeconomics
of
families.
Gut
is
considered
as
a
probable
factor
its
pathogenesis.
Multiple
bacterial
metabolites
such
short-chain
fatty
acids,
lipopolysaccharides,
neurotransmitters
that
are
responsible
for
incidence
progression
dementia
can
be
produced
by
microbiota.
Various
species
Bifidobacterium
breve
,
Akkermansia
muciniphila
Streptococcus
thermophilus
Escherichia
coli
Blautia
hydrogenotrophica
etc.
implicated
pathogenesis
dementia.
great
target
imitating
or
inhibiting
their
an
adjunctive
therapy
based
on
role
Therefore,
some
diets
prevent
decelerate
altering
composition.
Moreover,
probiotics
modulate
increasing
beneficial
bacteria
reducing
detrimental
species.
These
therapeutic
modalities
novel
methods
probably
safe
effective.
They
enhance
efficacy
traditional
medications
improve
cognitive
function.
Nutrients,
Год журнала:
2025,
Номер
17(3), С. 391 - 391
Опубликована: Янв. 22, 2025
Background/Objectives:
This
systematic
review
focused
on
collecting
the
most
significant
findings
impact
of
administration
Bifidobacterium
infantis
(or
longum
subps.
infantis)
and
breve,
alone,
in
conjunction,
or
combination
with
other
strains,
treatment
neurodegenerative
diseases
including
Alzheimer’s
disease
(AD)
Parkinson’s
(PD).
These
are
characterized
by
progressive
degeneration
neurons,
resulting
a
broad
spectrum
clinical
manifestations.
AD
is
typified
decline
cognitive
abilities,
while
PD
marked
motor
symptoms
associated
loss
dopamine
(DA).
Methods:
Five
different
databases,
ScienceDirect,
Scopus,
Wiley,
PubMed,
Web
Science
(WoS),
were
reviewed
studies
screened
for
inclusion
following
criteria:
(i)
that
specifically
evaluated
use
infantis,
subsp.
breve
as
therapeutic
intervention,
either
human
animal
models,
context
diseases;
(ii)
required
to
address
one
more
pathologies
examined
this
article,
included,
but
not
limited
to,
neurodegeneration,
disease,
oxidative
stress;
(iii)
full
text
was
accessible
online;
(iv)
article
written
English.
Results:
The
data
suggest
these
probiotics
have
neuroprotective
effects
may
delay
progression.
Conclusions:
study
provides
updated
insights
into
strains
like
PD,
main
limitation
being
number
trials
available.
Nutrients,
Год журнала:
2025,
Номер
17(3), С. 558 - 558
Опубликована: Янв. 31, 2025
Alzheimer’s
disease
(AD)
is
the
most
common
form
of
dementia
and
characterized
by
memory
impairment
that
significantly
interferes
with
daily
life.
Therapeutic
options
for
AD
substantively
modify
progression
remain
a
critical
unmet
need.
In
this
regard,
gut
microbiota
crucial
in
maintaining
human
health
regulating
metabolism
immune
responses,
increasing
evidence
suggests
probiotics,
particularly
beneficial
bacteria,
can
enhance
cognitive
functions.
Recent
studies
have
highlighted
positive
effects
Bifidobacterium
breve
MCC1274
(B.
MCC1274)
on
individuals
mild
(MCI)
schizophrenia.
Additionally,
oral
supplementation
B.
has
been
shown
to
effectively
prevent
decline
AppNL–G–F
mice.
relation
pathology,
found
reduce
amyloid-β
(Aβ)
accumulation
tau
phosphorylation
both
wild-type
(WT)
It
also
decreases
microglial
activation
increases
levels
synaptic
proteins.
review,
we
examine
AD,
exploring
potential
mechanisms
action
how
probiotic
strain
may
aid
preventing
or
treating
disease.
Furthermore,
discuss
broader
implications
improving
overall
host
provide
insights
into
future
research
directions
promising
therapy.
Allergology International,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 1, 2025
The
gut-brain
axis
exemplifies
the
bidirectional
connection
between
intestines
and
brain,
as
evidenced
by
impact
of
severe
stress
on
gastrointestinal
symptoms
including
abdominal
pain
diarrhea,
conversely,
influence
discomfort
mood.
Clinical
observations
support
notion
connection,
an
increased
prevalence
inflammatory
bowel
disease
(IBD)
in
patients
with
depression
anxiety,
well
association
changes
gut
microbiota
neurological
disorders
such
multiple
sclerosis,
Parkinson's
disease,
stroke
Alzheimer's
disease.
brain
communicate
via
complex
mechanisms
involving
cytokines,
immune
cells,
autonomic
nerves,
microbiota,
which
contribute
to
pathogenesis
certain
diseases.
Two
primary
pathways
mediate
information
exchange
intestinal
tract
brain:
signal
transduction
through
bloodstream
factors,
bacterial
metabolites
neural
pathways,
neurotransmitters
cytokines
within
nervous
system
interaction
nerve
cells
beyond.
In
recent
years,
basic
pathophysiology
have
been
gradually
elucidated.
Beyond
interaction,
emerging
evidence
suggests
extends
other
organs,
liver
lungs,
intricate
inter-organ
communication
pathways.
An
increasing
number
reports
this
clinical
cross-organ
interactions
underscore
potential
for
better
understanding
novel
therapeutic
strategies
targeting
inter-organs
networks.
Further
clarification
multiorgans
premises
transformative
insights
into
strategies.